D.E. Shaw / BridgeBio Pharma, Inc.
D.E. Shaw: reported share positions in BridgeBio Pharma, Inc..
D.E. Shaw · BridgeBio Pharma, Inc.
Recent reported positions (up to 20)
| Report period | Value (USD) | Quantity | Change |
|---|---|---|---|
| 2026-06-30 | 270586362.00 | 3633007.000000 | trim |
| 2026-03-31 | 295566561.00 | 65325486.000000 | add |
| 2025-12-31 | 169351231.00 | 2214031.000000 | trim |
| 2025-09-30 | 145361344.00 | 30904762.000000 | add |
| 2025-06-30 | 110526036.00 | 24142253.000000 | add |
| 2025-03-31 | 16134304.00 | 14833149.000000 | trim |
| 2024-12-31 | 44138299.00 | 51750000.000000 | trim |
| 2024-09-30 | 45819026.00 | 52330746.000000 | trim |
| 2024-06-30 | 62454133.00 | 66903128.000000 | trim |
| 2024-03-31 | 78907809.00 | 73992888.000000 | trim |
| 2023-12-31 | 106989622.00 | 74499865.000000 | trim |
| 2023-09-30 | 95079911.00 | 74916243.000000 | trim |
| 2023-06-30 | 82819577.00 | 82982986.000000 | add |
| 2023-03-31 | 64679496.00 | 43982021.000000 | add |
| 2022-12-31 | 20580279.00 | 2700824.000000 | add |
| 2022-09-30 | 23439000.00 | 2358069.000000 | trim |
| 2022-06-30 | 22232000.00 | 2448459.000000 | trim |
| 2022-03-31 | 26526000.00 | 4969028.000000 | add |
| 2021-12-31 | 21452000.00 | 1286089.000000 | add |
| 2021-09-30 | 7808000.00 | 166592.000000 | trim |
Recent source filings (up to 20)
| Report period | Filed | Form | Source |
|---|---|---|---|
| 2026-06-30 | 2026-08-14 00:00:00 | 13F-HR | Original filing |
| 2026-03-31 | 2026-05-15 00:00:00 | 13F-HR | Original filing |
| 2025-12-31 | 2026-02-17 00:00:00 | 13F-HR | Original filing |
| 2025-09-30 | 2025-11-14 00:00:00 | 13F-HR | Original filing |
| 2025-06-30 | 2025-08-14 00:00:00 | 13F-HR | Original filing |
| 2025-03-31 | 2025-05-15 00:00:00 | 13F-HR | Original filing |
| 2024-12-31 | 2025-02-14 00:00:00 | 13F-HR | Original filing |
| 2024-09-30 | 2024-11-14 00:00:00 | 13F-HR | Original filing |
| 2024-06-30 | 2024-08-14 00:00:00 | 13F-HR | Original filing |
| 2024-03-31 | 2024-05-15 00:00:00 | 13F-HR | Original filing |
| 2023-12-31 | 2024-02-14 00:00:00 | 13F-HR | Original filing |
| 2023-09-30 | 2023-11-14 00:00:00 | 13F-HR | Original filing |
| 2023-06-30 | 2023-08-14 00:00:00 | 13F-HR | Original filing |
| 2023-03-31 | 2023-05-15 00:00:00 | 13F-HR | Original filing |
| 2022-12-31 | 2023-02-14 00:00:00 | 13F-HR | Original filing |
| 2022-09-30 | 2022-11-14 00:00:00 | 13F-HR | Original filing |
| 2022-06-30 | 2022-08-15 00:00:00 | 13F-HR | Original filing |
| 2022-03-31 | 2022-05-16 00:00:00 | 13F-HR | Original filing |
| 2021-12-31 | 2022-02-14 00:00:00 | 13F-HR | Original filing |
| 2021-09-30 | 2021-11-15 00:00:00 | 13F-HR | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.